Zacks Investment Research · 9 Sept 2026positive
OptimumBank Holdings, Inc. (OPHC) was named to the Zacks Rank #1 (Strong Buy) value stocks list on September 9, 2026, alongside BP and CRD.B, according to a Zacks Investment Research article.
Why it matters — OPHC watchers would care because inclusion on a Zacks Strong Buy value stock list signals a favorable rating from a major research firm.
Zacks Investment Research · 31 Aug 2026positive
OptimumBank Holdings, Inc. (OPHC) was upgraded to a Zacks Rank #1 (Strong Buy), driven by growing optimism about its earnings prospects. The upgrade signals increased confidence in the company's near-term performance.
Why it matters — A Strong Buy rating from Zacks reflects heightened analyst confidence in OPHC's earnings outlook, which is a key signal for investors tracking the bank's prospects.
Zacks Investment Research · 31 Aug 2026positive
On August 31, 2026, OptimumBank Holdings, Inc. (OPHC) was named to Zacks Investment Research's Rank #1 (Strong Buy) value stocks list, alongside HRTG and MCY.
Why it matters — OPHC watchers would care because the company received a top Strong Buy rating from Zacks' value-stock screen, signaling favorable recognition in the research community.
Zacks Investment Research · 26 Aug 2026positive
Zacks Investment Research included OPHC on its Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026, alongside BTSG and ANIK. The designation reflects OPHC's recognition on Zacks' momentum screen.
Why it matters — OPHC watchers would care because inclusion on Zacks' Strong Buy momentum list signals elevated recognition of the stock by an independent research firm.
Zacks Investment Research · 26 Aug 2026positive
On August 26th, 2026, OptimumBank Holdings, Inc. (OPHC), along with BTSG, HRTG, UMC and MTG, was added to the Zacks Rank #1 (Strong Buy) List. The announcement was made by Zacks Investment Research.
Why it matters — OPHC watchers would note that the company has been newly included in Zacks' top-ranked Strong Buy list, reflecting a notable development in how the stock is rated by the research firm.